Fosravuconazole (L-lysine ethanolate)
Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate), a proagent of Ravuconazole, is an orally active broad spectrum antifungal agent. Fosravuconazole L-lysine ethanolate can be used for candidiasis, onychomycosis and parasitemia research[1][2][3].
Product Specifications
CAS Number
914361-45-8
Product Name Alternative
BMS-379224 (L-lysine ethanolate) ; E-1224 (L-lysine ethanolate)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Fungal; Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/fosravuconazole-l-lysine-ethanolate.html
Purity
99.86
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : 200 mg/mL (ultrasonic)
Smiles
N#CC1=CC=C(C2=CSC([C@H](C)[C@@](OCOP(O)(O)=O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)=N2)C=C1.CCO.N[C@H](C(O)=O)CCCCN
Molecular Formula
C31H40F2N7O8PS
Molecular Weight
739.73
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD44 Standard (DF1485), CF405S conjugate, 0.1mg/mL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF594 conjugate, 0.1mg/mL
Cytokeratin 8/18 (C-51), CF647 conjugate, 0.1mg/mL
Eosinophil Peroxidase (AHE-1), CF488A conjugate, 0.1mg/mL
